✨ Medicines and Drug Regulations
1094 NEW ZEALAND GAZETTE, No. 38 10 APRIL 2014
Product:
Pinorax
Active Ingredients:
Dantron 15mg/mL
Poloxamer 188 200mg/mL
Dosage Form:
Oral suspension
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturer:
Pinewood Laboratories Limited, Tipperary, Ireland
Note: This consent is given subject to the following condition:
• Pinorax may only be used for the prevention or treatment of constipation in the terminally ill.
Note: This renewed consent is valid for two years from 22 April 2014.
Dated this 3rd day of April 2014.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
go2187
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Dificid
Active Ingredient:
Fidaxomicin 200mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer:
Patheon Inc, Ontario, Canada
Product:
Erivedge
Active Ingredient:
Vismodegib 150mg
Dosage Form:
Capsule
New Zealand Sponsor:
Roche Products (NZ) Limited
Manufacturer:
Patheon Inc, Ontario, Canada
Product:
Ibugesic
Active Ingredient:
Ibuprofen 200mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
REX Medical Limited
Manufacturer:
Cipla Limited, Goa, India
Product:
Juvederm Hydrate
Active Ingredient:
Sodium hyaluronate 13.5mg
Dosage Form:
Solution for injection
New Zealand Sponsor:
Allergan New Zealand Limited
Manufacturer:
Allergan, Pringy, France
Dated this 3rd day of April 2014.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
go2186
Misuse of Drugs Act 1975
Misuse of Drugs (Prohibition of Cannabis Utensils and Methamphetamine Utensils) Notice 2014
Pursuant to section 22(1A) of the Misuse of Drugs Act 1975, the Minister of Health gives the following notice.
Notice
-
Title—This notice is the Misuse of Drugs (Prohibition of Cannabis Utensils and Methamphetamine Utensils) Notice 2014.
-
Commencement—This notice comes into force on 12 May 2014.
-
Interpretation—In this notice, unless the context otherwise requires—
Act means the Misuse of Drugs Act 1975.
cannabis means any of the following:
(a) A cannabis preparation as described in clause 1 of Part 1 of Schedule 2 of the Act;
(b) a cannabis fruit, cannabis plant, or cannabis seed as described in Part 1 of Schedule 3 of the Act.
cannabis utensil means any of the following utensils that may be used for administering cannabis, and that has 1 or more prohibited features:
(a) A bong;
(b) a hash pipe;
(c) a roach clip with a pincer or tweezer action.
methamphetamine means any of the following:
(a) The substance methamphetamine as described in clause 1 of Schedule 1 of the Act;
(b) the isomers of the substance mentioned in paragraph (a) whenever the existence of isomers of that kind is possible within the specific chemical designation;
Next Page →
NZ Gazette 2014, No 38
✨ LLM interpretation of page content
🏥
Renewal of Provisional Consent to the Distribution of Medicines
(continued from previous page)
🏥 Health & Social Welfare3 April 2014
Medicines Act 1981, Provisional Consent, Pinorax, Oral Suspension
- DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare3 April 2014
Medicines Act 1981, New Medicines, Dificid, Erivedge, Ibugesic, Juvederm Hydrate
- DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health
🏥 Misuse of Drugs (Prohibition of Cannabis Utensils and Methamphetamine Utensils) Notice 2014
🏥 Health & Social WelfareMisuse of Drugs Act 1975, Cannabis Utensils, Methamphetamine Utensils